EAM
Exome Asset Management Portfolio holdings
AUM
$110M
This Quarter Return
+0.6%
1 Year Return
+24.83%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$112M
AUM Growth
+$112M
(-3.8%)
Cap. Flow
-$7.72M
Cap. Flow
% of AUM
-6.87%
Top 10 Holdings %
Top 10 Hldgs %
40.26%
Holding
80
New
27
Increased
6
Reduced
11
Closed
28
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$5.2M |
| 2 |
Amgen
AMGN
|
$3.69M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$2.94M |
| 4 |
AUTL
Autolus Therapeutics
AUTL
|
$2.92M |
| 5 |
Disc Medicine
IRON
|
$2.75M |
Top Sells
| 1 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$4.64M |
| 2 |
Dr. Reddy's Laboratories
RDY
|
$3.79M |
| 3 |
Avidity Biosciences
RNA
|
$3.45M |
| 4 |
Celldex Therapeutics
CLDX
|
$2.98M |
| 5 |
Geron
GERN
|
$2.93M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$657B
| $8.78M | 7.82% | 9,700 | – | – |
|
|
2
Sarepta Therapeutics
SRPT
$1.78B
| $5.2M | 4.63% | +32,900 | New | +$5.2M |
|
|
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $4.74M | 4.22% | 33,200 -3,600 | -10% | -$514K |
|
4
TG Therapeutics
TGTX
$4.65B
| $4.48M | 3.99% | 251,600 +21,300 | +9% | +$379K |
|
5
Cigna
CI
$80.3B
| $4.03M | 3.59% | 12,200 -3,100 | -20% | -$1.02M |
|
6
Corbus Pharmaceuticals
CRBP
$115M
| $3.84M | 3.42% | 84,790 -3,056 | -3% | -$138K |
|
7
Insmed
INSM
$28.8B
| $3.81M | 3.39% | 56,800 -14,900 | -21% | -$998K |
|
|
8
Amgen
AMGN
$155B
| $3.69M | 3.28% | +11,800 | New | +$3.69M |
|
9
Travere Therapeutics
TVTX
$1.56B
| $3.64M | 3.24% | 443,379 +80,892 | +22% | +$665K |
|
10
Madrigal Pharmaceuticals
MDGL
$9.76B
| $3.03M | 2.69% | 10,800 +2,900 | +37% | +$812K |
|
|
AVDL
11
Avadel Pharmaceuticals
AVDL
$1.43B
| $2.94M | 2.62% | +209,092 | New | +$2.94M |
|
12
DexCom
DXCM
$29.5B
| $2.94M | 2.62% | 25,928 +1,100 | +4% | +$125K |
|
|
AUTL
13
Autolus Therapeutics
AUTL
$399M
| $2.92M | 2.6% | +839,472 | New | +$2.92M |
|
14
Intuitive Surgical
ISRG
$170B
| $2.83M | 2.52% | 6,358 | – | – |
|
|
15
Dr. Reddy's Laboratories
RDY
$11.8B
| $2.77M | 2.46% | 36,300 -49,700 | -58% | -$3.79M |
|
|
16
Disc Medicine
IRON
$2.07B
| $2.75M | 2.45% | +61,000 | New | +$2.75M |
|
17
Ascendis Pharma
ASND
$11.8B
| $2.73M | 2.43% | +20,000 | New | +$2.73M |
|
18
Kura Oncology
KURA
$686M
| $2.71M | 2.42% | +131,742 | New | +$2.71M |
|
19
Merus
MRUS
$4.98B
| $2.67M | 2.38% | +45,100 | New | +$2.67M |
|
20
Masimo
MASI
$7.59B
| $2.49M | 2.22% | +19,800 | New | +$2.49M |
|
|
CNTA
21
Centessa Pharmaceuticals
CNTA
$2.25B
| $2.48M | 2.21% | 274,900 | – | – |
|
22
Wave Life Sciences
WVE
$1.53B
| $2.44M | 2.17% | +488,135 | New | +$2.44M |
|
23
Guardant Health
GH
$8.41B
| $2.28M | 2.03% | 79,000 | – | – |
|
24
Cabaletta Bio
CABA
$133M
| $2.25M | 2% | +300,200 | New | +$2.25M |
|
25
Arvinas
ARVN
$568M
| $2.19M | 1.95% | +82,400 | New | +$2.19M |
|